Response to SARS-CoV-2 vaccination and antibodies persistence in multiple myeloma patients

被引：2
|
作者：
Pettine, Loredana [1 ]
Bortolotti, Marta [2 ]
Fattizzo, Bruno [1 ,2 ]
Da Via, Matteo C. [1 ,2 ]
Consonni, Dario [3 ]
Pompa, Alessandra [1 ]
Bolli, Niccolo [1 ,2 ]
Baldini, Luca [1 ,2 ]
机构：
[1] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Hematol Unit, Milan, Italy
[2] Univ Milan, Dept Oncol & Hemato Oncol, Milan, Italy
[3] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Epidemiol Unit, Milan, Italy
来源：
HEMATOLOGICAL ONCOLOGY | 2023年 / 41卷 / 01期
关键词：
multiple myeloma; response to vaccination; SARS-CoV-2; IMMUNE-RESPONSES; VACCINES;
D O I：
10.1002/hon.3051
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：210 / 212
页数：3
相关论文
共 50 条
  • [21] Longitudinal SARS-CoV-2 humoral response in MS patients with and without SARS-CoV-2 infection prior to vaccination
    van Dam, Koos P. J.
    Hogenboom, Laura
    Stalman, Eileen W.
    Kummer, Laura Y. L.
    Steenhuis, Maurice
    Keijser, Jim B. D.
    ten Brinke, Anja
    van Ham, S. Marieke
    Kuijpers, Taco W.
    Rispens, Theo
    Wieske, Luuk
    Eftimov, Filip
    Strijbis, Eva M.
    Killestein, Joep
    van Kempen, Zoe L. E.
    FRONTIERS IN NEUROLOGY, 2022, 13
  • [22] Persistence of SARS-CoV-2 antibodies in kidney transplant recipients
    Benotmane, Ilies
    Gautier Vargas, Gabriela
    Velay, Aurelie
    Wendling, Marie-Jose
    Perrin, Peggy
    Fafi-Kremer, Samira
    Caillard, Sophie
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 (06) : 2307 - 2310
  • [23] Serological response to SARS-CoV-2 vaccination in patients with immunobullous diseases
    Levian, B.
    Tukaj, S.
    Woodley, D. T.
    Kasperkiewicz, M.
    JEADV CLINICAL PRACTICE, 2024, 3 (05): : 1686 - 1689
  • [24] Multiple myeloma in times of SARS-CoV-2 in Mexico
    Ignacio-Ibarra, Gregorio
    Espinoza-Zamora, Jose R.
    Ramirez-Alvarado, Aline G.
    Ceballos-Lopez, Adrian A.
    GACETA MEDICA DE MEXICO, 2021, 157 : 141 - 147
  • [25] Vaccination for SARS-CoV-2 in Hematological Patients
    Riccardi, Niccolo
    Falcone, Marco
    Yahav, Dafna
    ACTA HAEMATOLOGICA, 2022, 145 (03) : 257 - 266
  • [26] Efficacy of SARS-CoV-2 vaccination in Multiple Sclerosis
    Gyang, T. V.
    Evans, J.
    Miller, J.
    Alcorn, K.
    Peng, J.
    Bell, E.
    Zeng, C.
    Gumina, R.
    Liu, S.
    Segal, B. M.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (1_SUPPL) : 80 - 80
  • [27] SARS-CoV-2 vaccination willingness and humoral vaccination response in radiation oncology patients
    Geinitz, Hans
    Silberberger, Elisabeth
    Spiegl, Kurt
    Feichtinger, Johann
    Wagner, Helga
    Hermann, Philipp
    Braeutigam, Elisabeth
    Track, Christine
    Weis, Eva Maria
    Venhoda, Clemens
    Huppert, Roswitha
    Spindelbalker-Renner, Barbara
    Zauner-Babor, Georgine
    Nyiri, Dalma Viktoria
    Karasek, Nicola
    Erdei, Mercedesz
    Gheju, Ruben
    Gruber, Georg
    Egger, Margot
    Dieplinger, Benjamin
    VACCINE, 2024, 42 (04) : 945 - 959
  • [28] Serum SARS-CoV-2 antibodies in HIV-1-infected patients after inactivated vaccination and SARS-CoV-2 infection
    Zhang, Xiaodi
    Han, Dating
    Wu, Nanping
    HELIYON, 2024, 10 (11)
  • [29] The Antibodies' Response to SARS-CoV-2 Vaccination: 1-Year Follow Up
    Nicolai, Eleonora
    Tomassetti, Flaminia
    Pelagalli, Martina
    Sarubbi, Serena
    Minieri, Marilena
    Nisini, Alberto
    Nuccetelli, Marzia
    Ciotti, Marco
    Pieri, Massimo
    Bernardini, Sergio
    BIOMEDICINES, 2023, 11 (10)
  • [30] Monitoring of SARS-CoV-2 Specific Antibodies after Vaccination
    Guiomar, Raquel
    Santos, Ana Joao
    Melo, Aryse Martins
    Costa, Ines
    Matos, Rita
    Rodrigues, Ana Paula
    Kislaya, Irina
    Silva, Anabela Santos
    Roque, Carla
    Nunes, Carla
    Aguiar, Joaquim
    Graca, Fatima
    Silva Graca, Antonio
    Machado, Ausenda
    VACCINES, 2022, 10 (02)
12345